American Century Companies’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$194K Buy
+62,909
New +$267K ﹤0.01% 2717
2025
Q2
Sell
-17,175
Closed -$85.9K 2854
2025
Q1
$85.9K Sell
17,175
-27,567
-62% -$175K ﹤0.01% 2833
2024
Q4
$323K Buy
44,742
+11,788
+36% +$90.1K ﹤0.01% 2658
2024
Q3
$202K Buy
32,954
+19,761
+150% +$134K ﹤0.01% 2756
2024
Q2
$87.7K Sell
13,193
-65,461
-83% -$483K ﹤0.01% 2834
2024
Q1
$801K Buy
78,654
+42,519
+118% +$432K ﹤0.01% 2247
2023
Q4
$407K Buy
36,135
+14,871
+70% +$62.1K ﹤0.01% 2450
2023
Q3
$55.3K Buy
21,264
+10,093
+90% +$29K ﹤0.01% 2799
2023
Q2
$39.4K Buy
+11,171
New +$50.2K ﹤0.01% 2776
2017
Q2
Sell
-88
Closed -$21K 1331
2017
Q1
$21K Sell
88
-7
-7% -$3.75K ﹤0.01% 1306
2016
Q4
$93K Buy
+95
New +$85.1K ﹤0.01% 1313

Other funds holding ALT